Palmieri Orazio, Bossa Fabrizio, Valvano Maria Rosa, Corritore Giuseppe, Latiano Tiziana, Martino Giuseppina, D'Incà Renata, Cucchiara Salvatore, Pastore Maria, D'Altilia Mario, Scimeca Daniela, Biscaglia Giuseppe, Andriulli Angelo, Latiano Anna
Division of Gastroenterology, "Casa Sollievo della Sofferenza" Hospital, IRCCS, San Giovanni Rotondo (FG), Italy.
Department of Surgical, Oncological, and Gastroenterological Sciences, University of Padua, Padua, Italy.
PLoS One. 2017 Jan 4;12(1):e0168821. doi: 10.1371/journal.pone.0168821. eCollection 2017.
Crohn's disease (CD) is a pathologic condition with different clinical expressions that may reflect an interplay between genetics and environmental factors. Recently, it has been highlighted that three genetic markers, NOD2, MHC and MST1, were associated to distinct CD sites, supporting the concept that genetic variations may contribute to localize CD. Genetic markers, previously shown to be associated with inflammatory bowel disease (IBD), were tested in CD patients with the aim to better dissect the genetic relationship between ileal, ileocolonic and colonic CD and ascertain whether a different genetic background would support the three disease sites as independent entities.
A panel of 29 SNPs of 19 IBD loci were analyzed by TaqMan SNP allelic discrimination method both evaluating their distinct contribute and analyzing all markers jointly.
Seven hundred and eight CD patients and 537 healthy controls were included in the study. Of the overall population of patients, 237 patients had an ileal involvement (L1), 171 a colonic localization (L2), and the 300 remaining an ileocolon location (L3). We confirmed the association for 23 of 29 variations (P < 0.05). Compared to healthy controls, 16 variations emerged as associated to an ileum disease, 7 with a colonic disease and 14 with an ileocolonic site (P < 0.05). Comparing ileum to colonic CD, 5 SNPs (17%) were differentially associated (P < 0.05). A genetic model score that aggregated the risks of 23 SNPs and their odds ratios (ORs), yielded an Area Under the Curve (AUC) of 0.70 for the overall CD patients. By analyzing each CD location, the AUC remained at the same level for the ileal and ileocolonic sites (0.73 and 0.72, respectively), but dropped to a 0,66 value in patients with colon localization.
Our findings reaffirm the existence of at least three different subgroups of CD patients, with a genetic signature distinctive for the three main CD sites.
克罗恩病(CD)是一种具有不同临床表现的病理状况,可能反映了遗传因素与环境因素之间的相互作用。最近,有研究强调,三种遗传标记物NOD2、MHC和MST1与不同的CD病变部位相关,这支持了遗传变异可能导致CD病变部位定位的概念。此前已证明与炎症性肠病(IBD)相关的遗传标记物,在CD患者中进行了检测,目的是更好地剖析回肠型、回结肠型和结肠型CD之间的遗传关系,并确定不同的遗传背景是否支持这三种疾病部位作为独立的实体。
采用TaqMan SNP等位基因鉴别法分析了19个IBD基因座的29个单核苷酸多态性(SNP),评估它们各自的贡献,并对所有标记物进行联合分析。
该研究纳入了708例CD患者和537例健康对照。在所有患者群体中,237例患者有回肠受累(L1),171例为结肠定位(L2),其余300例为回结肠定位(L3)。我们证实了29个变异中有23个存在关联(P < 0.05)。与健康对照相比,16个变异与回肠疾病相关,7个与结肠疾病相关,14个与回结肠部位相关(P < 0.05)。比较回肠型与结肠型CD,5个SNP(17%)存在差异关联(P < 0.05)。一个综合了23个SNP风险及其比值比(OR)的遗传模型评分,在所有CD患者中得到的曲线下面积(AUC)为0.70。通过分析每个CD病变部位,回肠和回结肠部位的AUC保持在相同水平(分别为0.73和0.72),但结肠定位患者的AUC降至0.66。
我们的研究结果再次证实,至少存在三个不同的CD患者亚组,其遗传特征在三种主要的CD病变部位具有独特性。